Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | GAPDH | P04406 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7353467 | 0.89 | HPGD (0.60) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL5045391 | 0.82 | HPGD (0.53) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL1264102 | 0.82 | HPGD (0.53) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL4775992 | 0.82 | HPGD (0.53) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL11167825 | 0.81 | — | — | |
| SCHEMBL7537697 | 0.80 | HPGD (0.56) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL11840769 | 0.80 | HPGD (0.51) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL28879909 | 0.80 | TAAR1 (0.53) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| Hydrochloric Acid SCHEMBL4775231 | 0.80 | HPGD (0.51) | HPGDALDH1A1CYP2C19RAB9APOLB | |
| SCHEMBL15178187 | 0.79 | HPGD (0.50) | HPGDALDH1A1CYP2C19RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069683-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20090062573-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062573-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | ADH1C, ADH1A, ADH5 | HPGD 1827/4885ALDH1A1 26/4885CYP2C19 1167/4885 |
| US-20100069683-A1 | Organic metal compound and process for preparing optically-active alcohols using the same | ADH1C, ADH1A, ADH5 | HPGD 1827/4885ALDH1A1 26/4885CYP2C19 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.